Hims offers several products to help prevent and treat hair loss. Some are only available with a prescription. We break these products down for you in our review ... take one pill a day—but ...

Founded in 2017, Hims is a telemedicine platform that offers medical services and treatments related to sexual health, hair loss, anxiety ... from a few dollars per pill to close to $1,000 ...

But with GLP-1 sales vanishing, Hims is left banking on generic weight-loss pills and its core business in hair-loss and ED treatments. While that business is solid, it doesn't justify the lofty ...

Telehealth company Hims & Hers Health (HIMS ... triggering mixed reviews from analysts about the future of its weight loss business. See what stocks are receiving Strong Buy ratings from top ...

Hims & Hers is set to continue offering weight-loss pills and personalized weight-loss support, including nutrition plans and coaching. Outside of weight-loss care, the company saw its subscriber ...

Hims & Hers Health is a top growth stock with strong cash flow, no debt, and an innovative AI-powered platform. Learn more on ...

Hims & Hers (HIMS ... Yemi Okupe revealed a major shift. Future weight-loss offerings will be “primarily composed” of generic weight-loss pills and an older GLP-1 drug called liraglutide.

Hims & Hers has risen since November 2024, outperforming the S&P 500. Click here to see why HIMS stock is a Buy.

Hims & Hers (HIMS), the millennial-skewed telehealth company, saw its stock tumble nearly 9% on Tuesday, as the company braces for big regulatory shifts in the weight-loss drug industry.

But with GLP-1 sales vanishing, Hims is left banking on generic weight-loss pills and its core business in hair-loss and ED treatments. While that business is solid, it doesn't justify the lofty ...